WHEN HISTORY WENT WRONG
CONSEQUENCES, NOT PAPERWORK
THE SYSTEM DESIGNED
TO CATCH IT EARLY
100

Q: The 18-year-old research participant whose death reshaped modern clinical trial oversight in the U.S.

A: Who is Jesse Gelsinger?

100

Q: The approximate settlement amount paid in response to the Trovan trial litigation and related claims.

A: What is $75 million?

100

Q: The federal framework that governs human subjects protections in U.S. research.

A: What is the Common Rule?


200

Q: The disease outbreak during which a controversial drug trial took place in Nigeria in 1996.

A: What is meningitis?

200

Q: FDA actions taken to pause studies when serious safety concerns or compliance failures are identified.

A: What are clinical holds?

200

Q: This oversight body reviews protocols, monitors risk, and enforces participant protections at the institutional level.

A: What is the IRB?


300

Q: The pharmaceutical company responsible for the Trovan trial during that outbreak.

A: What is Pfizer?

300

Q: The process that requires prompt disclosure of serious and unexpected adverse events to regulators and oversight bodies.

A: What is safety reporting?

300

Q: A regulated disclosure intended to prevent financial interests from influencing study design, conduct, or reporting.

A: What is Financial Conflict of Interest?

M
e
n
u